PL2643010T3 - Biologicznie aktywny kompleks i jego otrzymywanie - Google Patents

Biologicznie aktywny kompleks i jego otrzymywanie

Info

Publication number
PL2643010T3
PL2643010T3 PL11804746T PL11804746T PL2643010T3 PL 2643010 T3 PL2643010 T3 PL 2643010T3 PL 11804746 T PL11804746 T PL 11804746T PL 11804746 T PL11804746 T PL 11804746T PL 2643010 T3 PL2643010 T3 PL 2643010T3
Authority
PL
Poland
Prior art keywords
preparation
biologically active
active complex
complex
biologically
Prior art date
Application number
PL11804746T
Other languages
English (en)
Inventor
Catharina Svanborg
Kenneth Hun Mok
Maria Trulsson
Ann-Kristin Mossberg
Petter Storm
Ching Shing Ho
Original Assignee
Hamlet Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1019937.0A external-priority patent/GB201019937D0/en
Priority claimed from GBGB1019936.2A external-priority patent/GB201019936D0/en
Application filed by Hamlet Pharma Ab filed Critical Hamlet Pharma Ab
Publication of PL2643010T3 publication Critical patent/PL2643010T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL11804746T 2010-11-24 2011-11-24 Biologicznie aktywny kompleks i jego otrzymywanie PL2643010T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1019937.0A GB201019937D0 (en) 2010-11-24 2010-11-24 Biologically active complex and its preparation
GBGB1019936.2A GB201019936D0 (en) 2010-11-24 2010-11-24 Therapeutic method
EP11804746.3A EP2643010B1 (en) 2010-11-24 2011-11-24 Biologically active complex and its preparation

Publications (1)

Publication Number Publication Date
PL2643010T3 true PL2643010T3 (pl) 2017-05-31

Family

ID=45444635

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11804746T PL2643010T3 (pl) 2010-11-24 2011-11-24 Biologicznie aktywny kompleks i jego otrzymywanie

Country Status (7)

Country Link
US (2) US9085643B2 (pl)
EP (1) EP2643010B1 (pl)
DK (1) DK2643010T3 (pl)
ES (1) ES2613986T3 (pl)
HU (1) HUE031912T2 (pl)
PL (1) PL2643010T3 (pl)
WO (1) WO2012069836A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079362A1 (en) 2009-01-09 2010-07-15 Hamlet Pharma Ab Complex and production process
WO2012069836A2 (en) 2010-11-24 2012-05-31 Hamlet Pharma Ab Biologically active complex and its preparation
CA2842377C (en) * 2011-07-19 2019-08-27 Ovizio Imaging Systems N.V. A method and system for detecting and/or classifying cancerous cells in a cell sample
HUE038910T2 (hu) 2012-08-09 2018-12-28 Hamlet Pharma Ab Profilaktikus és gyógytáp terápia
GB2536650A (en) 2015-03-24 2016-09-28 Augmedics Ltd Method and system for combining video-based and optic-based augmented reality in a near eye display
US20190185851A1 (en) * 2015-09-09 2019-06-20 Theoria Science Inc. Exosome secretion inhibitor
GB201621752D0 (en) * 2016-12-20 2017-02-01 Hamlet Pharma Ab Therapeutically active complexes
JP6917164B2 (ja) * 2017-03-07 2021-08-11 雪印メグミルク株式会社 小胞体ストレス軽減用組成物及び該組成物を含む食品、医薬品、飼料
JP6917163B2 (ja) * 2017-03-07 2021-08-11 雪印メグミルク株式会社 小胞体ストレス軽減用組成物及び該組成物を含む食品、医薬品、飼料
JP6917165B2 (ja) * 2017-03-07 2021-08-11 雪印メグミルク株式会社 小胞体ストレス軽減用組成物及び該組成物を含む食品、医薬品、飼料
GB201707715D0 (en) * 2017-05-14 2017-06-28 Hamlet Pharma Ab Preperation of biologically active complexes
US12458411B2 (en) 2017-12-07 2025-11-04 Augmedics Ltd. Spinous process clamp
US12521201B2 (en) 2017-12-07 2026-01-13 Augmedics Ltd. Spinous process clamp
WO2019211741A1 (en) 2018-05-02 2019-11-07 Augmedics Ltd. Registration of a fiducial marker for an augmented reality system
WO2019243547A1 (en) 2018-06-20 2019-12-26 Hamlet Pharma Ab Therapeutically active complexes
US11766296B2 (en) 2018-11-26 2023-09-26 Augmedics Ltd. Tracking system for image-guided surgery
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US12178666B2 (en) 2019-07-29 2024-12-31 Augmedics Ltd. Fiducial marker
US11980506B2 (en) 2019-07-29 2024-05-14 Augmedics Ltd. Fiducial marker
US20220323391A1 (en) * 2019-08-20 2022-10-13 Hamlet Pharma Ab Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy
US11382712B2 (en) 2019-12-22 2022-07-12 Augmedics Ltd. Mirroring in image guided surgery
US11389252B2 (en) 2020-06-15 2022-07-19 Augmedics Ltd. Rotating marker for image guided surgery
US12239385B2 (en) 2020-09-09 2025-03-04 Augmedics Ltd. Universal tool adapter
US12502163B2 (en) 2020-09-09 2025-12-23 Augmedics Ltd. Universal tool adapter for image-guided surgery
GB202015836D0 (en) 2020-10-06 2020-11-18 Hamlet Pharma Ab Compositions
US11896445B2 (en) 2021-07-07 2024-02-13 Augmedics Ltd. Iliac pin and adapter
US12150821B2 (en) 2021-07-29 2024-11-26 Augmedics Ltd. Rotating marker and adapter for image-guided surgery
US12475662B2 (en) 2021-08-18 2025-11-18 Augmedics Ltd. Stereoscopic display and digital loupe for augmented-reality near-eye display
WO2023203521A1 (en) 2022-04-21 2023-10-26 Augmedics Ltd. Systems and methods for medical image visualization
IL319523A (en) 2022-09-13 2025-05-01 Augmedics Ltd Augmented reality glasses for image-guided medical intervention
GB202303177D0 (en) * 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69837719T2 (de) * 1997-11-21 2008-01-31 Nya Hamlet Pharma Ab Herstellungsverfahren von lactalbumin
GB9725126D0 (en) 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
WO2001017524A1 (en) 1999-09-09 2001-03-15 Efa Sciences Llc. Methods for treating cell proliferative disorders including cancer
US6639089B2 (en) 2000-11-08 2003-10-28 Soda Aromatic Co., Ltd. Anticancer agents, perfumes or foods and drinks
GB0205347D0 (en) * 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
KR100716119B1 (ko) * 2005-10-24 2007-05-10 (주)케어젠 모발 성장을 촉진하는 펩티드 및 이를 이용한 화장품
US20100029557A1 (en) 2006-11-17 2010-02-04 Jens Sigh Alpha-lactalbumin composition
WO2008138348A1 (en) 2007-05-09 2008-11-20 Nya Hamlet Pharma Ab Preparation of complexed lactalbumin
WO2010079362A1 (en) * 2009-01-09 2010-07-15 Hamlet Pharma Ab Complex and production process
WO2010131237A1 (en) 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
WO2012069836A2 (en) 2010-11-24 2012-05-31 Hamlet Pharma Ab Biologically active complex and its preparation

Also Published As

Publication number Publication date
WO2012069836A2 (en) 2012-05-31
US20150344526A1 (en) 2015-12-03
US9487561B2 (en) 2016-11-08
WO2012069836A3 (en) 2012-08-09
EP2643010B1 (en) 2016-11-16
DK2643010T3 (en) 2017-02-27
EP2643010A2 (en) 2013-10-02
HUE031912T2 (en) 2017-08-28
US9085643B2 (en) 2015-07-21
US20140051636A1 (en) 2014-02-20
ES2613986T3 (es) 2017-05-29

Similar Documents

Publication Publication Date Title
PL2643010T3 (pl) Biologicznie aktywny kompleks i jego otrzymywanie
IL221511A (en) Arilatriazolones associated with bis aryl and their use
GB201012175D0 (en) Procedure and mechanisms
ZA201208173B (en) Peptices and their use
IL226904A (en) Inganol-3-acetylates iii and Inganol-3-carbamates
ZA201207331B (en) Concentrated protein formulations and uses thereof
IL223050A0 (en) Substituted 5 - fluoro - 1h- pyrazolopyridines and use thereof
PL2571807T3 (pl) Sferyczny proszek i jego wytwarzanie
SI2606120T1 (sl) Človeške facilitacijske celice in njihova uporaba
EP2657188A4 (en) FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
ZA201302537B (en) Stable and soluble antibodies
SI2605757T1 (sl) Formulacije na osnovi nalbufina in njihove uporabe
PL2563131T3 (pl) Kompozycja szkodnikobójcza i jej zastosowanie
ZA201207242B (en) Pesticidal composition and its use
PL2563133T3 (pl) Kompozycja szkodnikobójcza i jej zastosowanie
PT2521445T (pt) Formulação e utilização da mesma
PL2563134T3 (pl) Kompozycja szkodnikobójcza i jej zastosowanie
PT2563806E (pt) Leucolectinas humanas e suas utilizações
GB201006479D0 (en) Garment and use thereof
GB2503802B (en) Caspofungin analog, and Preparation Method and Uses thereof
EP2621490A4 (en) PROPARGYL-TRIFLUOROMETHOXY-AMINO-BENZOTHIAZOLE DERIVATIVES, PREPARATION THEREOF AND USE THEREOF
GB201019937D0 (en) Biologically active complex and its preparation
HU1000564D0 (en) Active chair
GB201012660D0 (en) Inhaler and formulation
GB201013491D0 (en) Functionalised biologically active surfaces